COPENHAGEN, Denmark, April 25, 2024 Ascendis Pharma A/S today announced it will report first quarter 2024 financial results and provide a business update on Thursday, May 2, 2024, after the.
Ventyx Biosciences Reports Fourth Quarter And Full Year 2023 Financial Results And Highlights Recent Corporate Progress menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Ventyx to host virtual investor event on March 11th to provide clinical updates on our NLRP3 portfolio and from the open-label extension of the VTX002.